Vital Options presents Advocacy in Action (AIA), in partnership with the ESMO Cancer Patient Working Group and in collaboration with the ECCO Patient Advisory Committee. This six-part AIA Forum will bring together influential leaders in cancer advocacy, to address the core issues that impact cancer survivorship. In this episode, David Kerr, discusses the importance of [...]

Prof. Michael Baumann, MD is the President of the European CanCer Organization and the Congress Chair for this 2011 European Multidisciplinary Cancer Congress in Stockholm. In this segment he discusses the theme of personalized medicine for the 2011 congress as well as how they have incorporated more patients and advocates into their ongoing agenda. The [...]

  Prof. Vincenzo Valentini, MD discusses the EMCC 2011 meeting from the European Soceity of Radiotherapy and Oncology perspective.  He talks about some of the conference highlights as well as his goals as the current president of ESTRO. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in part, by:   [...]

Prof. Keith Kerr, MD, FRCPath discusses the emerging role of biomarkers and targeted therapies in lung cancer and how personalized medicine is truly the future of cancer treatment. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in part, by:   VIDEO TRANSCRIPT Selma Schimmel, Founder & CEO, Vital Options International: [...]

Prof. Thierry Le Chevalier, MD discusses his teaching lecture on the management of early stage non-small cell lung cancer and how targeted therapies and personalized medicine are changing the face of lung cancer. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in part, by:   VIDEO TRANSCRIPT Selma Schimmel, Founder [...]

Prof. Michael Marberger, MD, FRCS discusses the highlights in advanced prostate cancer therapy treatments at the 2011 European Multidisciplinary Cancer Conference in Stockholm. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in part, by:   VIDEO TRANSCRIPT Selma Schimmel, Founder & CEO, Vital Options International: This is Selma Schimmel at [...]

Prof. Per-Anders Abrahamsson, MD discusses the highlights in prostate cancer at the 2011 European Multidisciplinary Cancer Conference in Stockholm. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in part, by: VIDEO TRANSCRIPT Selma Schimmel, Founder & CEO, Vital Options International: This is Selma Schimmel at the Multidisciplinary Cancer Congress 2011 [...]

Prof. Per-Anders Abrahamsson, MD discusses the lack of standardized screening guidelines for prostate cancer in Europe and around the world. He also talks about how the advocate community can help spread the word and educate men and women about prostate cancer. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in [...]

Prof. Bernard Escudier, MD discusses the major advances in kidney cancer over the past several years as well as his research on the AXIS Trial. In addition, Prof. Escudier discusses the signs of kidney cancer, risk factors and questions you should ask your doctor. The Group Room at the 2011 European Multidisciplinary Cancer Conference was [...]

Prof. Hans-Joachim Schmoll, MD, PhD discusses the highlights in colorectal cancer research and treatments at the 2011 European Multidisciplinary Cancer Conference in Stockholm. The Group Room at the 2011 European Multidisciplinary Cancer Conference was made possible, in part, by:   VIDEO TRANSCRIPT Selma Schimmel, Founder & CEO, Vital Options International: This is Selma Schimmel at [...]